COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,725 Articles (22,502 medRxiv, 8,223 bioRxiv)

Most recent first Previous |  Page 1368: Articles 13671-13680  | Next

Detection of B.1.351 and B.1.1.7 SARS-CoV-2 variants in Monterrey metropolitan area in Northeast Mexico
Galan-Huerta, K. A., Garza-de-la-Pena, E., Elizondo-Valdez, G. V., Herrera-Saldivar, M. F., Rivas-Estilla, A. M., Lozano-Sepulveda, S. A., Martinez-Acuna, N., Arellanos-Soto, D., Ramos-Jimenez, J.
10.1101/2021.06.21.21258579 — Posted: 2021-06-28
Rapid protocols to support Covid-19 clinical diagnosis based on hematological parameters
Gomes, J. C., Barbosa, V. A. d. F., de Santana, M. A., de Lima, C. L., Calado, R. B., Bertoldo Junior, C. R., Albuquerque, J. E. d. A., de Souza, R. G., de Araujo, R. J. E., Moreno, G. M. M., Soares, L. A. L., Mattos Junior, L. A. R., de Souza, R. E., dos Santos, W. P.
10.1101/2021.06.21.21259252 — Posted: 2021-06-28
Development and validation of blood-based prognostic biomarkers for severity of COVID disease outcome using EpiSwitch 3D genomic regulatory immuno-genetic profiling.
Hunter, E., Koutsothanasi, C., Wilson, A., Santos, F. C., Salter, M., Westra, J., Powell, R., Dring, A., Brajer, P., Egan, B., Matthew, P., Catriona, W., Aemilia, K., Thomas, L., Ramadass, A., Messner, W., Brunton, A., Lyski, Z., Robbins, P., Mellor, J., Vancheeswaran, R., Barlow, A., Pchejetski, D., Akoulitchev, A.
10.1101/2021.06.21.21259145 — Posted: 2021-06-28
Emergence of immune escape at dominant SARS-CoV-2 killer T-cell epitope
Dolton, G., Rius, C., Hasan, M. S., Szomolay, B., Behiry, E., Whalley, T., Southgate, J. A., COVID-19 Genomics UK Consortium, , Morin, T., Topley, K., Tan, L. R., Fuller, A., Wall, A., Goulder, P. J., Spiller, B., Jones, L. C., Connor, T. R., Sewell, A. K.
10.1101/2021.06.21.21259010 — Posted: 2021-06-28
Rapid, large-scale wastewater surveillance and automated reporting system enabled early detection of nearly 85% of COVID-19 cases on a University campus
Karthikeyan, S., Nguyen, A., McDonald, D., Zong, Y., Ronquillo, N., Ren, J., Zou, J., Farmer, S., Humphrey, G., Henderson, D., Javidi, T., Messer, K., Anderson, C., Schooley, R., Martin, N., Knight, R.
10.1101/2021.06.18.21259162 — Posted: 2021-06-27
Seroconversion panels demonstrate anti-SARS-CoV-2 antibody development after administration of the mRNA-1273 vaccine
Belda, F., Mora, O., Lopez-Martinez, M., Torres, N., Vivanco, A., Christie, R., Crowley, M.
10.1101/2021.06.20.21258152 — Posted: 2021-06-27
Association between preference and e-learning readiness among the Bangladeshi female nursing students in the Covid-19 pandemic: a cross-sectional study
Kabir, H., Tonmon, T. T., Hasan, M. K., Mitra, D. K.
10.1101/2021.06.20.21259188 — Posted: 2021-06-27
Taiwan on track to end third COVID-19 community outbreak
Nordling, T. E. M., Rain, Y.-H.
10.1101/2021.06.20.21259178 — Posted: 2021-06-27
Effectiveness of Face Masks in Blocking the Transmission of SARS-CoV-2: a Preliminary Evaluation of Masks Used by SARS-CoV-2-Infected Individuals
Mello, V. M., Eller, C. M., Salvio, A. L., Nascimento, F. F., Figueiredo, C. M., Silva, E. S. R. F., Sousa, P. S. F., Costa, P. F., Paiva, A. A. P., Mares-Guias, M. A. M. M., Lemos, E. R. S., Horta, M. A. P.
10.1101/2021.06.20.21259167 — Posted: 2021-06-27
The evaluation of factors affecting antibody response after administration of the BNT162b2 vaccine: A prospective study in Japan
Mitsunaga, T., Ohtaki, Y., Seki, Y., Yoshioka, M., Mori, H., Suzuka, M., Mashiko, S., Takeda, S., Mashiko, K.
10.1101/2021.06.20.21259177 — Posted: 2021-06-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).